Varta
← Back to stories

From The Economic Times

Center-Right Owned by Bennett, Coleman & Co.

Johnson & Johnson's prostate cancer drug shrinks tumors in early-stage trial

Johnson & Johnson's prostate cancer drug shrinks tumors in early-stage trial

RSS excerpt

Johnson & Johnson reported results from an early-stage trial of their prostate cancer drug JNJ-6143. The trial involved patients with advanced prostate cancer who had undergone multiple treatments. Results showed 77% of patients experienced a significant drop in PSA levels after treatment…

✦ Single Source 1 news outlet reporting

Fact-Check & Bias Analysis

Reported by a single newsroom so far. Other outlets have not independently corroborated this story yet.

Coverage Bias Distribution

Based on 1 reporting publisher
Left / Center-Left 0 (0%)
Center 0 (0%)
Center-Right / Right 1 (100%)

Read more news

See all latest stories →